Matches in Nanopublications for { ?s ?p "[Reduced efficacy of the Plk1 inhibitor BI 2536 on the progression of hepatocellular carcinoma due to low intratumoral drug levels.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 3 of
3
with 100 items per page.
- NP631183.RAwCccM52X2n4n99sGAFzkjbi7sO2HV585OyDi-cg3NSM130_assertion description "[Reduced efficacy of the Plk1 inhibitor BI 2536 on the progression of hepatocellular carcinoma due to low intratumoral drug levels.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP631183.RAwCccM52X2n4n99sGAFzkjbi7sO2HV585OyDi-cg3NSM130_provenance.
- NP994005.RA00U_F__nJlu_xOG-erH605an33_FBssqhZ9W5GqkHdw130_assertion description "[Reduced efficacy of the Plk1 inhibitor BI 2536 on the progression of hepatocellular carcinoma due to low intratumoral drug levels.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP994005.RA00U_F__nJlu_xOG-erH605an33_FBssqhZ9W5GqkHdw130_provenance.
- assertion description "[Reduced efficacy of the Plk1 inhibitor BI 2536 on the progression of hepatocellular carcinoma due to low intratumoral drug levels.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.